Literature DB >> 18985705

Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database.

Tarek A Hammad1, Mara A McAdams, Andrea Feight, Solomon Iyasu, Gerald J Dal Pan.   

Abstract

PURPOSE: To determine (1) the positive predictive value (PPV) of multiple Read/OXMIS codes to identify incident acute myocardial infarction (AMI) cases in General Practice Research Database (GPRD); (2) the ability to capture the correct timing of the clinical event.
METHODS: A random sample of 238 records (from 155 general practitioner (GP) practices) with AMI codes, between 1 January 1997 and 31 December 2004, was selected from GPRD. Questionnaires were sent to the GPs to verify the diagnosis and timing of code-identified incident AMI events and collect supporting information. We calculated the PPV of the AMI codes as the proportion of code-identified AMIs that the GPs confirmed as AMI cases. Two physicians from Food and Drug administration (FDA), blinded to the GP response, reviewed the supporting hospital records returned by GPs for 98 AMI cases.
RESULTS: A total of 217 questionnaires were completed (91% response rate). The PPV of the AMI codes was 93% (201/217). Thirty one (15%) cases had a different event date than the one recorded in the electronic medical records (EMR); 28 (90%) of the dates were within 15 days. One GP indicated that a patient had a previous AMI, 110 days before the codes that captured the AMI diagnosis. A total of 159 (79%) AMI cases were hospitalized; hospital records were provided for 98 patients. Physician review of the hospital records found that 96% of these records had enough information for classification, but not independent diagnosis, of AMI.
CONCLUSIONS: Information in GPRD is sufficient to identify incident AMI cases and determine the event date with reasonable accuracy. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18985705     DOI: 10.1002/pds.1672

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  32 in total

1.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

Review 2.  Validity of diagnostic coding within the General Practice Research Database: a systematic review.

Authors:  Nada F Khan; Sian E Harrison; Peter W Rose
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

3.  Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network.

Authors:  Christopher G Rowan; Steven M Brunelli; Jeffrey Munson; James Flory; Peter P Reese; Sean Hennessy; James Lewis; Daniel Mines; Jeffrey S Barrett; Warren Bilker; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-03-16       Impact factor: 2.890

4.  Accuracy of pneumonia hospital admissions in a primary care electronic medical record database.

Authors:  Sharon B Meropol; Joshua P Metlay
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-02-28       Impact factor: 2.890

5.  A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction.

Authors:  A Afonso; S Schmiedl; C Becker; S Tcherny-Lessenot; P Primatesta; E Plana; P Souverein; Y Wang; J C Korevaar; J Hasford; R Reynolds; M C H de Groot; R Schlienger; O Klungel; M Rottenkolber
Journal:  Eur J Clin Pharmacol       Date:  2016-05-24       Impact factor: 2.953

6.  Risk and predictors of cardiovascular disease in psoriasis: a population-based study.

Authors:  Hilal Maradit-Kremers; Ross A Dierkhising; Cynthia S Crowson; Murat Icen; Floranne C Ernste; Marian T McEvoy
Journal:  Int J Dermatol       Date:  2013-01       Impact factor: 2.736

7.  Psoriasis and cardiovascular risk: strength in numbers.

Authors:  Joel M Gelfand; Rahat S Azfar; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2010-04       Impact factor: 8.551

8.  The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

Authors:  Ada Man; Yanyan Zhu; Yuqing Zhang; Maureen Dubreuil; Young Hee Rho; Christine Peloquin; Robert W Simms; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

9.  Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program.

Authors:  Sarah L Cutrona; Sengwee Toh; Aarthi Iyer; Sarah Foy; Gregory W Daniel; Vinit P Nair; Daniel Ng; Melissa G Butler; Denise Boudreau; Susan Forrow; Robert Goldberg; Joel Gore; David McManus; Judith A Racoosin; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-06-29       Impact factor: 2.890

10.  Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study.

Authors:  Na Lu; Devyani Misra; Tuhina Neogi; Hyon K Choi; Yuqing Zhang
Journal:  Arthritis Rheumatol       Date:  2015-10       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.